
Healthcare enterprise executive with 30 years of experience in corporate strategy, mergers and acquisitions, venture investment, and platform development across regulated U.S. and international markets. Proven leader in buy-side and sell-side transactions, distressed asset acquisition, transaction structuring, valuation, transformation, and post-merger integration within healthcare organizations. Recognized for aligning capital allocation, EBITDA improvement, regulatory governance, and enterprise growth strategy to drive sustainable value creation. Board-facing executive with direct oversight of P&L performance, valuation modeling, investor relations, CMS/OIG regulatory strategy, and integration governance.